I had bought OTIC stock back in December I think, based on InvestorsOberserver's evaluation of fundamentals, short term and long term price expectations, and analyst stock target. I sold at a modest loss when the stock dropped 7% or so below my buy point, which is how I operate. Had I held it though I would have lost 50% of my investment on 2/22 when the company announced a failure in the phase 3 trial of a primary drug in it's repertoire. Just wanted to highlight the risk potential when investing in small cap medical companies that don't have a confirmed viable product to tout. The financials look good on paper and there is a lot of positive potential but if the drug or treatment doesn't work out you're portfolio can take a major hit.
